Victory Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Victory Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-55,337	Closed	-$1.12M	–	2887
2021 Q3	$1.12M	Buy	55,337 +14,584	+36%	+$403K	﹤0.01%	1808
2021 Q2	$1.52M	Sell	40,753 -33,265	-45%	-$1.02M	﹤0.01%	1718
2021 Q1	$1.89M	Buy	74,018 +19,352	+35%	+$494K	﹤0.01%	1666
2020 Q4	$1.2M	Sell	54,666 -1,918	-3%	-$42.2K	﹤0.01%	1707
2020 Q3	$1.02M	Buy	56,584 +6,310	+13%	+$131K	﹤0.01%	1697
2020 Q2	$1.28M	Sell	50,274 -49,622	-50%	-$1.07M	﹤0.01%	1612
2020 Q1	$1.84M	Buy	99,896 +89,395	+851%	+$1.74M	﹤0.01%	1635
2019 Q4	$231K	Buy	10,501 +1,151	+12%	+$23.2K	﹤0.01%	2275
2019 Q3	$134K	Buy	+9,350	New	+$134K	﹤0.01%	2346

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Victory Capital Management's DRNA Position: Q4 2021 in Review

Victory Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 55,337 shares — an estimated $1.12M sold.

Victory Capital Management first reported a position in DRNA in Q3 2019 and held it in 9 quarters. The position peaked at $1.89M in Q1 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Victory Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Victory Capital Management sold 55,337 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.12M.
Victory Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2019 and held it in 9 quarters.
Victory Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $1.89M in Q1 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Victory Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.